Publication | Closed Access

New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts

Drug TargetingOncologyVivo StudiesMedicineRadionuclide TherapyImmunologyTheranosticsPeptide TherapeuticRadiopharmaceutical TherapyInvasive Cancer CellsTumor TargetingPharmacologyTumor MicroenvironmentTumor Biology